Justin Meiklem

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

2024 /

Vancouver, British Columbia and Rehovot, Israel – August 23, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024. On the call, CEO Ilan Sobel will discuss commercial progress and […]

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time Read More »

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

2024 /

Vancouver, British Columbia and Rehovot, Israel – June 28, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD) has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 share units at USD $7.17 per unit raising a total of USD $4,329,982.62 (approx. CAD $5,926,000).

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes Read More »

BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024

2024 /

Vancouver, British Columbia and Rehovot, Israel – June 24, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024. CEO Ilan Sobel is scheduled to

BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024 Read More »

BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

2024 /

Vancouver, British Columbia and Rehovot, Israel – June 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), announced today that its board of directors have approved a private placement of up to 697,350 units at a price of USD $7.17 per unit (approx. CAD $9.82) for gross proceeds of up to

BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes Read More »

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024

2024 /

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 12, 2024) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Sidoti Small-Cap Investor Conference, being held June 12-13, 2024. CEO Ilan Sobel is scheduled

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024 Read More »

The Biotech Journey

BioHarvest Sciences Announces Record $2 Million Monthly Sales

2024 /

VINIA® Subscription Growth Drives 101% Year-over-Year Increase in May Product Sales Orders; Cumulative Customer Reviews Surpass 5,000 Vancouver, British Columbia and Rehovot, Israel – June 6, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), a company pioneering its patented Botanical Synthesis technology platform, today announced that VINIA®, the first commercialized product

BioHarvest Sciences Announces Record $2 Million Monthly Sales Read More »